Skilled Nursing Facility at Home Trial
1 other identifier
interventional
650
1 country
2
Brief Summary
Skilled Nursing Facility at Home is a multicenter randomized control trial that aims to evaluate a home-based model of providing post-acute care (PAC). We will enroll 650 hospitalized patients who require rehabilitation and/or skilled-nursing support upon discharge and randomly assign them to an intervention (home-based PAC) or control arm (facility-based PAC). Our design includes two different health systems in Massachusetts: Baystate Health and UMass Memorial Health. We will perform 1:1 randomization between the intervention and control arm using a permuted block design, with stratification by clinical site and payor group. The primary outcome of the trial will be the difference in hospital readmission and mortality rates from the time of enrollment to 30 days after enrollment. Secondary clinical, functional, and cost outcomes include length of stay in PAC, difference in health-related quality of life (HRQoL), and healthcare cost and utilization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedStudy Start
First participant enrolled
August 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
March 11, 2026
March 1, 2026
2.3 years
August 7, 2024
March 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
30-Day Readmission and Mortality
Hospital readmission rates and mortality rates between the intervention and control groups in the first 30 days after enrollment
From time of enrollment to 30 days after enrollment
Secondary Outcomes (6)
90- and 180- day Readmission and Mortality
From time of enrollment, up to 6 months post-enrollment
Days Alive
From time of enrollment, up to 6 months post-enrollment
Activities of Daily Living
From time of enrollment, up to 6 months post-enrollment
Healthcare Costs
From time of enrollment, up to 6 months post-enrollment
Mortality rate
From time of enrollment to 6 months post-enrollment
- +1 more secondary outcomes
Study Arms (2)
Facility-based
NO INTERVENTIONFacility based post acute care at a skilled nursing facility, as is the standard care model.
Home-based
ACTIVE COMPARATORHome-based Post-Acute Care
Interventions
Patients randomized to the intervention group will receive skilled nursing and rehabilitative care at home upon discharge from the hospital, or when eligible for skilled-nursing facility care when requiring a step up in services at home. Home care will be delivered and overseen by a multidisciplinary clinical team, which will develop individualized care plans based on diagnosis, specific rehabilitation objectives, and broader goals of care.
Eligibility Criteria
You may qualify if:
- Age 18 or older
- Admitted to an inpatient unit OR receiving home health and requiring an escalation to skilled-nursing facility care
- Require post-acute care in a skilled nursing facility based on the clinical inpatient team's assessment (or, if the participant is coming from home, based on the home health team's assessment)
- Pass the home readiness assessment
- Reside within Greater Worcester or Greater Springfield
You may not qualify if:
- Inability to return to a home residence where care can be provided
- Inability for patient or their proxy to provide informed consent for the study
- Requires long-term care
- Requires palliative or hospice care
- On active chemotherapy
- Post-transplant surgery
- Requires hemodialysis
- Requires radiation therapy
- Requires two-person assist or mechanical lift
- Expresses unwillingness to be randomized to SNF OR SNF at Home care
- Considered clinically inappropriate by SNF at Home clinical team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Massachusetts, Worcesterlead
- Baystate Healthcollaborator
- UMass Memorial Healthcollaborator
- Massachusetts Executive Office of Health and Human Services (EOHHS)collaborator
Study Sites (2)
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
UMass Memorial Medical Center
Worcester, Massachusetts, 02446, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Principal Investigator
University of Massachusetts, Worcester
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 7, 2024
First Posted
August 9, 2024
Study Start
August 26, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share